AI Drug Discovery Startup Valo Raises $190 Million And Unveils Cancer Therapy Programs

Valo Health, which is developing a drug discovery platform powered by both artificial intelligence and large patient datasets, announced Monday that it’s working on multiple targets that are implicated in different cancers. And to move things along, it’s raised $190 million in a series B round, which gives it a total of about $285 million raised to date.